Fig. 2From: Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanningProgression-free survival for patients with skull base meningiomas separated by low risk (WHO grade I) and high-risk (WHO grades II and III) histologyBack to article page